On the other hand, re-expression of PKD1 to rescue its tumor suppressive functions in terms of invasiveness and metastasis by general suppression of methylation using the epi-drug decitabine has shown promising results in in vivo models (Borges et al., 2013), but the compound is not specific to PKD1. Here, PKD1 is linked to neoplasm.